cytokine neutralization Search Results


94
Chem Impex International carboxyphenol ba
Carboxyphenol Ba, supplied by Chem Impex International, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/carboxyphenol ba/product/Chem Impex International
Average 94 stars, based on 1 article reviews
carboxyphenol ba - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

90
Nagai Nori USA INC neutralizing antibodies to cytokines
Neutralizing Antibodies To Cytokines, supplied by Nagai Nori USA INC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/neutralizing antibodies to cytokines/product/Nagai Nori USA INC
Average 90 stars, based on 1 article reviews
neutralizing antibodies to cytokines - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Biacore neutrall-sallon cytokine peptides
Neutrall Sallon Cytokine Peptides, supplied by Biacore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/neutrall-sallon cytokine peptides/product/Biacore
Average 90 stars, based on 1 article reviews
neutrall-sallon cytokine peptides - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Becton Dickinson cytokine-neutralizing antibodies
Cytokine Neutralizing Antibodies, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cytokine-neutralizing antibodies/product/Becton Dickinson
Average 90 stars, based on 1 article reviews
cytokine-neutralizing antibodies - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Double Helix cytokine neutralizing antibodies
Cytokine Neutralizing Antibodies, supplied by Double Helix, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cytokine neutralizing antibodies/product/Double Helix
Average 90 stars, based on 1 article reviews
cytokine neutralizing antibodies - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Bio X Cell antibodies depletion specific cell populations or neutralization specific cytokines
CBA/J mice ( n = 6 mice/group/timepoint) were administered isotype ( a – d ), anti-CD8 ( e , f ), or anti-CD4 ( g , h ) antibodies. Mice then received either C. neoformans Δ sgl1 (white symbols) or PBS (black symbols). After 30 days, mice were challenged with C. neoformans WT (day 0). On days −15, −1, 7, 15, and 24, mice were assessed for T cell-derived <t>cytokines</t> (IFNγ, IL-17A) via intracellular cytokine staining. Graphed data represents the mean ± SD from 2 independent experiments ( n = 3 mice/group/timepoint for each biological replicate). Representative flow cytometry plots for days −1 and 7 for each group are shown, which were gated from live, CD45 + singlets (gating scheme shown in Supplementary Fig. ). Significance was determined by a two-way ANOVA using Šídák’s multiple comparisons test for P value adjustment, and significance is denoted as * P < 0.05; ** P < 0.01; *** P < 0.005; **** P < 0.001.
Antibodies Depletion Specific Cell Populations Or Neutralization Specific Cytokines, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/antibodies depletion specific cell populations or neutralization specific cytokines/product/Bio X Cell
Average 90 stars, based on 1 article reviews
antibodies depletion specific cell populations or neutralization specific cytokines - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Becton Dickinson neutralizing anti-cytokine mab against il-4
CBA/J mice ( n = 6 mice/group/timepoint) were administered isotype ( a – d ), anti-CD8 ( e , f ), or anti-CD4 ( g , h ) antibodies. Mice then received either C. neoformans Δ sgl1 (white symbols) or PBS (black symbols). After 30 days, mice were challenged with C. neoformans WT (day 0). On days −15, −1, 7, 15, and 24, mice were assessed for T cell-derived <t>cytokines</t> (IFNγ, IL-17A) via intracellular cytokine staining. Graphed data represents the mean ± SD from 2 independent experiments ( n = 3 mice/group/timepoint for each biological replicate). Representative flow cytometry plots for days −1 and 7 for each group are shown, which were gated from live, CD45 + singlets (gating scheme shown in Supplementary Fig. ). Significance was determined by a two-way ANOVA using Šídák’s multiple comparisons test for P value adjustment, and significance is denoted as * P < 0.05; ** P < 0.01; *** P < 0.005; **** P < 0.001.
Neutralizing Anti Cytokine Mab Against Il 4, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/neutralizing anti-cytokine mab against il-4/product/Becton Dickinson
Average 90 stars, based on 1 article reviews
neutralizing anti-cytokine mab against il-4 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Blackwell Science Ltd antibodies neutralizing cytokines
CBA/J mice ( n = 6 mice/group/timepoint) were administered isotype ( a – d ), anti-CD8 ( e , f ), or anti-CD4 ( g , h ) antibodies. Mice then received either C. neoformans Δ sgl1 (white symbols) or PBS (black symbols). After 30 days, mice were challenged with C. neoformans WT (day 0). On days −15, −1, 7, 15, and 24, mice were assessed for T cell-derived <t>cytokines</t> (IFNγ, IL-17A) via intracellular cytokine staining. Graphed data represents the mean ± SD from 2 independent experiments ( n = 3 mice/group/timepoint for each biological replicate). Representative flow cytometry plots for days −1 and 7 for each group are shown, which were gated from live, CD45 + singlets (gating scheme shown in Supplementary Fig. ). Significance was determined by a two-way ANOVA using Šídák’s multiple comparisons test for P value adjustment, and significance is denoted as * P < 0.05; ** P < 0.01; *** P < 0.005; **** P < 0.001.
Antibodies Neutralizing Cytokines, supplied by Blackwell Science Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/antibodies neutralizing cytokines/product/Blackwell Science Ltd
Average 90 stars, based on 1 article reviews
antibodies neutralizing cytokines - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Schering-Plough corporation human cytokine-neutralizing antibodies
(a) Bacille Calmette–Guérin (BCG) dose-dependent interferon (IFN)-γ production by human peripheral blood mononuclear cells (PBMCs). PBMCs were incubated with medium or five different doses of BCG ranging from 2·5 × 103 to 2·5 × 106 colony-forming units (CFU)/ml for 3 days and then assayed for IFN-γ production in the conditioned media. (b) The roles of endogenous T helper 1 (Th1) and Th2 cytokines in BCG-induced IFN-γ production by human PBMCs. PBMCs were incubated with 2·5 × 105 CFU/ml of BCG in the presence or absence of <t>indicated</t> <t>cytokine-neutralizing</t> antibodies (3 µg/ml) for 3 days and then assayed for IFN-γ production in the conditioned media. Species and isotype-matched control antibodies had no effect on IFN-γ production (data not shown). *Significantly decreased.
Human Cytokine Neutralizing Antibodies, supplied by Schering-Plough corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human cytokine-neutralizing antibodies/product/Schering-Plough corporation
Average 90 stars, based on 1 article reviews
human cytokine-neutralizing antibodies - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Genzyme cytokine-neutralizing antibodies
(a) Bacille Calmette–Guérin (BCG) dose-dependent interferon (IFN)-γ production by human peripheral blood mononuclear cells (PBMCs). PBMCs were incubated with medium or five different doses of BCG ranging from 2·5 × 103 to 2·5 × 106 colony-forming units (CFU)/ml for 3 days and then assayed for IFN-γ production in the conditioned media. (b) The roles of endogenous T helper 1 (Th1) and Th2 cytokines in BCG-induced IFN-γ production by human PBMCs. PBMCs were incubated with 2·5 × 105 CFU/ml of BCG in the presence or absence of <t>indicated</t> <t>cytokine-neutralizing</t> antibodies (3 µg/ml) for 3 days and then assayed for IFN-γ production in the conditioned media. Species and isotype-matched control antibodies had no effect on IFN-γ production (data not shown). *Significantly decreased.
Cytokine Neutralizing Antibodies, supplied by Genzyme, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cytokine-neutralizing antibodies/product/Genzyme
Average 90 stars, based on 1 article reviews
cytokine-neutralizing antibodies - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
PeproTech exogenous cytokines, neutralizing antibodies or isotype controls
(a) Bacille Calmette–Guérin (BCG) dose-dependent interferon (IFN)-γ production by human peripheral blood mononuclear cells (PBMCs). PBMCs were incubated with medium or five different doses of BCG ranging from 2·5 × 103 to 2·5 × 106 colony-forming units (CFU)/ml for 3 days and then assayed for IFN-γ production in the conditioned media. (b) The roles of endogenous T helper 1 (Th1) and Th2 cytokines in BCG-induced IFN-γ production by human PBMCs. PBMCs were incubated with 2·5 × 105 CFU/ml of BCG in the presence or absence of <t>indicated</t> <t>cytokine-neutralizing</t> antibodies (3 µg/ml) for 3 days and then assayed for IFN-γ production in the conditioned media. Species and isotype-matched control antibodies had no effect on IFN-γ production (data not shown). *Significantly decreased.
Exogenous Cytokines, Neutralizing Antibodies Or Isotype Controls, supplied by PeproTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/exogenous cytokines, neutralizing antibodies or isotype controls/product/PeproTech
Average 90 stars, based on 1 article reviews
exogenous cytokines, neutralizing antibodies or isotype controls - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Celltech Inc neutralizing cytokine antibodies
(a) Bacille Calmette–Guérin (BCG) dose-dependent interferon (IFN)-γ production by human peripheral blood mononuclear cells (PBMCs). PBMCs were incubated with medium or five different doses of BCG ranging from 2·5 × 103 to 2·5 × 106 colony-forming units (CFU)/ml for 3 days and then assayed for IFN-γ production in the conditioned media. (b) The roles of endogenous T helper 1 (Th1) and Th2 cytokines in BCG-induced IFN-γ production by human PBMCs. PBMCs were incubated with 2·5 × 105 CFU/ml of BCG in the presence or absence of <t>indicated</t> <t>cytokine-neutralizing</t> antibodies (3 µg/ml) for 3 days and then assayed for IFN-γ production in the conditioned media. Species and isotype-matched control antibodies had no effect on IFN-γ production (data not shown). *Significantly decreased.
Neutralizing Cytokine Antibodies, supplied by Celltech Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/neutralizing cytokine antibodies/product/Celltech Inc
Average 90 stars, based on 1 article reviews
neutralizing cytokine antibodies - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


CBA/J mice ( n = 6 mice/group/timepoint) were administered isotype ( a – d ), anti-CD8 ( e , f ), or anti-CD4 ( g , h ) antibodies. Mice then received either C. neoformans Δ sgl1 (white symbols) or PBS (black symbols). After 30 days, mice were challenged with C. neoformans WT (day 0). On days −15, −1, 7, 15, and 24, mice were assessed for T cell-derived cytokines (IFNγ, IL-17A) via intracellular cytokine staining. Graphed data represents the mean ± SD from 2 independent experiments ( n = 3 mice/group/timepoint for each biological replicate). Representative flow cytometry plots for days −1 and 7 for each group are shown, which were gated from live, CD45 + singlets (gating scheme shown in Supplementary Fig. ). Significance was determined by a two-way ANOVA using Šídák’s multiple comparisons test for P value adjustment, and significance is denoted as * P < 0.05; ** P < 0.01; *** P < 0.005; **** P < 0.001.

Journal: Mucosal Immunology

Article Title: Vaccine protection by Cryptococcus neoformans Δ sgl1 is mediated by γδ T cells via TLR2 signaling

doi: 10.1038/s41385-022-00570-3

Figure Lengend Snippet: CBA/J mice ( n = 6 mice/group/timepoint) were administered isotype ( a – d ), anti-CD8 ( e , f ), or anti-CD4 ( g , h ) antibodies. Mice then received either C. neoformans Δ sgl1 (white symbols) or PBS (black symbols). After 30 days, mice were challenged with C. neoformans WT (day 0). On days −15, −1, 7, 15, and 24, mice were assessed for T cell-derived cytokines (IFNγ, IL-17A) via intracellular cytokine staining. Graphed data represents the mean ± SD from 2 independent experiments ( n = 3 mice/group/timepoint for each biological replicate). Representative flow cytometry plots for days −1 and 7 for each group are shown, which were gated from live, CD45 + singlets (gating scheme shown in Supplementary Fig. ). Significance was determined by a two-way ANOVA using Šídák’s multiple comparisons test for P value adjustment, and significance is denoted as * P < 0.05; ** P < 0.01; *** P < 0.005; **** P < 0.001.

Article Snippet: All antibodies for depletion of specific cell populations or neutralization of specific cytokines were purchased from BioXCell.

Techniques: Derivative Assay, Staining, Flow Cytometry

CBA/J mice ( n = 8–10 mice/group) were neutralized of specific cytokines and/or cell types (as indicated in the figure legends) prior to vaccination with C. neoformans Δ sgl1 (white symbols) or PBS controls (black symbols), and neutralizations continued for the entirety of the experiment at noted intervals. a , b . Vaccinated and unvaccinated mice were challenged with C. neoformans WT strain and assessed for survival during specific cytokine neutralization ( a ) or cytokine neutralization during either CD4 or CD8 T cell deficiency ( b ). Survival significance was determined by the Mantel–Cox log-rank test, and denoted on each graph: a . # P < 0.001 for Δ sgl1 /Isotype → WT vs. Δ sgl1 /anti-IL-17A → WT; b . % P < 0.001 for Δ sgl1 /Isotype → WT vs. Δ sgl1 /anti-CD4 + anti-IL-17A → WT or Δ sgl1 /anti-CD8 + anti-IL-17A → WT.

Journal: Mucosal Immunology

Article Title: Vaccine protection by Cryptococcus neoformans Δ sgl1 is mediated by γδ T cells via TLR2 signaling

doi: 10.1038/s41385-022-00570-3

Figure Lengend Snippet: CBA/J mice ( n = 8–10 mice/group) were neutralized of specific cytokines and/or cell types (as indicated in the figure legends) prior to vaccination with C. neoformans Δ sgl1 (white symbols) or PBS controls (black symbols), and neutralizations continued for the entirety of the experiment at noted intervals. a , b . Vaccinated and unvaccinated mice were challenged with C. neoformans WT strain and assessed for survival during specific cytokine neutralization ( a ) or cytokine neutralization during either CD4 or CD8 T cell deficiency ( b ). Survival significance was determined by the Mantel–Cox log-rank test, and denoted on each graph: a . # P < 0.001 for Δ sgl1 /Isotype → WT vs. Δ sgl1 /anti-IL-17A → WT; b . % P < 0.001 for Δ sgl1 /Isotype → WT vs. Δ sgl1 /anti-CD4 + anti-IL-17A → WT or Δ sgl1 /anti-CD8 + anti-IL-17A → WT.

Article Snippet: All antibodies for depletion of specific cell populations or neutralization of specific cytokines were purchased from BioXCell.

Techniques: Neutralization

C57BL/6 (black symbols) or TLR2 −/− (white symbols) were administered C. neoformans Δ sgl1 and assessed for T cell-derived cytokines via intracellular cytokine stimulation on days −30 (uninfected; a ), −27 ( b ), and −23 ( c ). 30 days after C. neoformans Δ sgl1 administration, mice were challenged with C. neoformans WT and assessed for T cell-derived cytokines via intracellular cytokine stimulation on days −1 (unchallenged; d ), 3 ( e ), and 7 ( f ). At all timepoints, mice were assessed for the total number of γδ T, CD4 + , and CD8 + T cells as well as the number of IFNγ- or IL-17A-producing subsets of these cells. Graphed data represent the mean ± SD and are representative of 1–2 independent experiments ( n = 3–6 mice/timepoint/group). Significance was determined by a two-way ANOVA using Šídák’s multiple comparisons test for P value adjustment, and denoted as * P < 0.05, ** P < 0.01, *** P < 0.005, **** P < 0.001.

Journal: Mucosal Immunology

Article Title: Vaccine protection by Cryptococcus neoformans Δ sgl1 is mediated by γδ T cells via TLR2 signaling

doi: 10.1038/s41385-022-00570-3

Figure Lengend Snippet: C57BL/6 (black symbols) or TLR2 −/− (white symbols) were administered C. neoformans Δ sgl1 and assessed for T cell-derived cytokines via intracellular cytokine stimulation on days −30 (uninfected; a ), −27 ( b ), and −23 ( c ). 30 days after C. neoformans Δ sgl1 administration, mice were challenged with C. neoformans WT and assessed for T cell-derived cytokines via intracellular cytokine stimulation on days −1 (unchallenged; d ), 3 ( e ), and 7 ( f ). At all timepoints, mice were assessed for the total number of γδ T, CD4 + , and CD8 + T cells as well as the number of IFNγ- or IL-17A-producing subsets of these cells. Graphed data represent the mean ± SD and are representative of 1–2 independent experiments ( n = 3–6 mice/timepoint/group). Significance was determined by a two-way ANOVA using Šídák’s multiple comparisons test for P value adjustment, and denoted as * P < 0.05, ** P < 0.01, *** P < 0.005, **** P < 0.001.

Article Snippet: All antibodies for depletion of specific cell populations or neutralization of specific cytokines were purchased from BioXCell.

Techniques: Derivative Assay

Upon intranasal administration of C. neoformans Δ sgl1 , the yeast cells travel down the bronchioles into the alveoli (1) encountering resident alveolar macrophages (AM), dendritic cells (DCs), and γδ T cells. Both sterylglucosides (SGs) and the glucuronoxylomannan (GXM)-rich capsule of C. neoformans Δ sgl1 can be found on the surface of yeast cells or/and in the extracellular environment. γδ T cells recognize and respond directly to C. neoformans Δ sgl1 via a toll-like receptor 2 (TLR2)-directed mechanism (2) producing the host-protective cytokines IFNγ and IL-17A leading to a pro-inflammatory lung cytokine environment with augmented leukocyte recruitment to the lungs (3) including neutrophils and monocytes that mediate early host control by limiting C. neoformans Δ sgl1 replication. Antigen-presenting cells (APCs) become activated, phagocytose the yeast, and travel to the lung-draining lymph node to prime naive CD4 + or CD8 + T cells when CD4 + T cells are absent (4). The naive T cells differentiate into protectively polarized IFNγ- and IL-17A-producing T cells and travel to the lungs (5) resulting in the pulmonary clearance of the mutant. While most recruited leukocytes die upon resolution of the inflammatory response, a small percentage of αβ and γδ T cells become host-protective memory T cells (6) that rapidly respond upon a subsequent WT challenge, promptly producing both IFNγ and IL-17A and conferring strong vaccine protection. Graphical illustration created with BioRender.com.

Journal: Mucosal Immunology

Article Title: Vaccine protection by Cryptococcus neoformans Δ sgl1 is mediated by γδ T cells via TLR2 signaling

doi: 10.1038/s41385-022-00570-3

Figure Lengend Snippet: Upon intranasal administration of C. neoformans Δ sgl1 , the yeast cells travel down the bronchioles into the alveoli (1) encountering resident alveolar macrophages (AM), dendritic cells (DCs), and γδ T cells. Both sterylglucosides (SGs) and the glucuronoxylomannan (GXM)-rich capsule of C. neoformans Δ sgl1 can be found on the surface of yeast cells or/and in the extracellular environment. γδ T cells recognize and respond directly to C. neoformans Δ sgl1 via a toll-like receptor 2 (TLR2)-directed mechanism (2) producing the host-protective cytokines IFNγ and IL-17A leading to a pro-inflammatory lung cytokine environment with augmented leukocyte recruitment to the lungs (3) including neutrophils and monocytes that mediate early host control by limiting C. neoformans Δ sgl1 replication. Antigen-presenting cells (APCs) become activated, phagocytose the yeast, and travel to the lung-draining lymph node to prime naive CD4 + or CD8 + T cells when CD4 + T cells are absent (4). The naive T cells differentiate into protectively polarized IFNγ- and IL-17A-producing T cells and travel to the lungs (5) resulting in the pulmonary clearance of the mutant. While most recruited leukocytes die upon resolution of the inflammatory response, a small percentage of αβ and γδ T cells become host-protective memory T cells (6) that rapidly respond upon a subsequent WT challenge, promptly producing both IFNγ and IL-17A and conferring strong vaccine protection. Graphical illustration created with BioRender.com.

Article Snippet: All antibodies for depletion of specific cell populations or neutralization of specific cytokines were purchased from BioXCell.

Techniques: Mutagenesis

(a) Bacille Calmette–Guérin (BCG) dose-dependent interferon (IFN)-γ production by human peripheral blood mononuclear cells (PBMCs). PBMCs were incubated with medium or five different doses of BCG ranging from 2·5 × 103 to 2·5 × 106 colony-forming units (CFU)/ml for 3 days and then assayed for IFN-γ production in the conditioned media. (b) The roles of endogenous T helper 1 (Th1) and Th2 cytokines in BCG-induced IFN-γ production by human PBMCs. PBMCs were incubated with 2·5 × 105 CFU/ml of BCG in the presence or absence of indicated cytokine-neutralizing antibodies (3 µg/ml) for 3 days and then assayed for IFN-γ production in the conditioned media. Species and isotype-matched control antibodies had no effect on IFN-γ production (data not shown). *Significantly decreased.

Journal:

Article Title: Dose-dependent synergy of Th1-stimulating cytokines on bacille Calmette-Gu?rin-induced interferon-? production by human mononuclear cells

doi: 10.1111/j.1365-2249.2007.03413.x

Figure Lengend Snippet: (a) Bacille Calmette–Guérin (BCG) dose-dependent interferon (IFN)-γ production by human peripheral blood mononuclear cells (PBMCs). PBMCs were incubated with medium or five different doses of BCG ranging from 2·5 × 103 to 2·5 × 106 colony-forming units (CFU)/ml for 3 days and then assayed for IFN-γ production in the conditioned media. (b) The roles of endogenous T helper 1 (Th1) and Th2 cytokines in BCG-induced IFN-γ production by human PBMCs. PBMCs were incubated with 2·5 × 105 CFU/ml of BCG in the presence or absence of indicated cytokine-neutralizing antibodies (3 µg/ml) for 3 days and then assayed for IFN-γ production in the conditioned media. Species and isotype-matched control antibodies had no effect on IFN-γ production (data not shown). *Significantly decreased.

Article Snippet: Human cytokine-neutralizing antibodies were obtained from Schering for IFN-α (sheep polyclone) and from R&D Systems (Minneapolis, MN, USA) for IL-2 (clone 5334·21, mouse IgG1), IL-10 (clone 23738·111, mouse IgG2b) and IL-12 (goat polyclone).

Techniques: Incubation